These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9221295)

  • 21. Quantitating tumor glucose metabolism with FDG and PET.
    Hawkins RA; Choi Y; Huang SC; Messa C; Hoh CK; Phelps ME
    J Nucl Med; 1992 Mar; 33(3):339-44. PubMed ID: 1740699
    [No Abstract]   [Full Text] [Related]  

  • 22. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures.
    Theodore WH; Newmark ME; Sato S; Brooks R; Patronas N; De La Paz R; DiChiro G; Kessler RM; Margolin R; Manning RG
    Ann Neurol; 1983 Oct; 14(4):429-37. PubMed ID: 6416141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 24. [The value of emission computed tomography with 18 F-fluorodeoxyglucose (PET scan with 18FDG)].
    Belhocine T
    JBR-BTR; 2003; 86(1):23-5. PubMed ID: 12807071
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of relocatable stereotactic frame to integrate positron emission tomography and computed tomography images: application in human malignant brain tumours.
    Thomas DG; Gill SS; Wilson CB; Darling JL; Parkins CS
    Stereotact Funct Neurosurg; 1990; 54-55():388-92. PubMed ID: 2080354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 28. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
    Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 31. Positron emission tomography in familial Alzheimer disease.
    Kennedy AM; Rossor MN; Frackowiak RS
    Alzheimer Dis Assoc Disord; 1995; 9(1):17-20. PubMed ID: 7605617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography.
    Hinkin CH; van Gorp WG; Mandelkern MA; Gee M; Satz P; Holston S; Marcotte TD; Evans G; Paz DH; Ropchan JR
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):180-7. PubMed ID: 7626961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of positron emission tomography.
    Maisey M
    Trans Med Soc Lond; 1992-1993; 109():52-61. PubMed ID: 1365497
    [No Abstract]   [Full Text] [Related]  

  • 34. [Localized imaging with 18F-fluorodeoxyglucose].
    Paul R; Ahonen A
    Duodecim; 1985; 101(12):1167-77. PubMed ID: 3874764
    [No Abstract]   [Full Text] [Related]  

  • 35. Clarification of a fractional uptake concept.
    Thie JA
    J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
    [No Abstract]   [Full Text] [Related]  

  • 36. Positron emission tomography and the lung.
    Hughes JM
    Br J Hosp Med; 1996 Jul 10-Aug 20; 56(2-3):86-9. PubMed ID: 8832042
    [No Abstract]   [Full Text] [Related]  

  • 37. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 38. FDG-PET in oncology: there's more to it than looking at pictures.
    Fischman AJ; Alpert NM
    J Nucl Med; 1993 Jan; 34(1):6-11. PubMed ID: 8418272
    [No Abstract]   [Full Text] [Related]  

  • 39. [Musical-verbal hallucinations and their correlation with electroencephalography and PET findings. Case report].
    Erkwoh R; Ebel H; Kachel F; Reiche W; Ringelstein EB; Zimmermann J; Büll U; Sass H
    Nervenarzt; 1992 Mar; 63(3):169-74. PubMed ID: 1579175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET and neurobehavioral evidence of tetrabromoethane encephalopathy.
    Morrow LA; Callender T; Lottenberg S; Buchsbaum MS; Hodgson MJ; Robin N
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):431-5. PubMed ID: 2136397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.